- Home
- MTCH vs RVMD Comparison
MTCH vs RVMD Comparison
Compare MTCH & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- RVMD
- Stock Information
- Founded
- MTCH 1986
- RVMD 2014
- Country
- MTCH United States
- RVMD United States
- Employees
- MTCH N/A
- RVMD N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTCH Technology
- RVMD Health Care
- Exchange
- MTCH Nasdaq
- RVMD Nasdaq
- Market Cap
- MTCH 8.0B
- RVMD 7.5B
- IPO Year
- MTCH 2015
- RVMD 2020
- Fundamental
- Price
- MTCH $32.63
- RVMD $54.53
- Analyst Decision
- MTCH Hold
- RVMD Strong Buy
- Analyst Count
- MTCH 16
- RVMD 16
- Target Price
- MTCH $35.56
- RVMD $76.63
- AVG Volume (30 Days)
- MTCH 3.9M
- RVMD 2.2M
- Earning Date
- MTCH 11-04-2025
- RVMD 11-06-2025
- Dividend Yield
- MTCH 2.33%
- RVMD N/A
- EPS Growth
- MTCH N/A
- RVMD N/A
- EPS
- MTCH 2.03
- RVMD N/A
- Revenue
- MTCH $3,450,576,000.00
- RVMD N/A
- Revenue This Year
- MTCH $2.43
- RVMD N/A
- Revenue Next Year
- MTCH $4.49
- RVMD $462.53
- P/E Ratio
- MTCH $16.06
- RVMD N/A
- Revenue Growth
- MTCH N/A
- RVMD N/A
- 52 Week Low
- MTCH $26.39
- RVMD $29.17
- 52 Week High
- MTCH $39.20
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- MTCH 38.91
- RVMD 73.56
- Support Level
- MTCH $31.98
- RVMD $52.48
- Resistance Level
- MTCH $33.33
- RVMD $56.08
- Average True Range (ATR)
- MTCH 0.76
- RVMD 1.94
- MACD
- MTCH 0.09
- RVMD 0.36
- Stochastic Oscillator
- MTCH 49.91
- RVMD 84.92
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.